Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,773	2,025	1,245	1,128	2,581	1,599
Market Cap Growth	70.13%	62.59%	10.35%	-56.28%	61.40%	-12.69%
Enterprise Value	3,559	1,812	1,061	1,121	2,589	1,264
Last Close Price	191.69	107.15	71.42	66.80	99.67	64.17
PE Ratio	76.97	-	23.88	-	45.18	-
Forward PE	35.68	53.58	35.07	-	-	33.23
PS Ratio	14.70	12.11	9.48	5.75	10.69	9.78
PB Ratio	3.97	2.44	1.78	1.89	3.14	2.25
P/TBV Ratio	6.13	4.42	4.18	8.11	7.85	-
P/FCF Ratio	122.65	21.26	27.04	8.99	36.86	31.90
P/OCF Ratio	118.21	20.86	25.12	8.19	32.76	29.30
PEG Ratio	-	3.57	2.34	-	-	1.61
EV/Sales Ratio	14.17	10.84	8.08	5.71	10.72	7.73
EV/EBITDA Ratio	56.47	31.11	22.90	27.11	22.09	18.31
EV/EBIT Ratio	123.39	78.73	108.04	369.11	39.07	30.77
EV/FCF Ratio	115.71	19.03	23.04	8.93	36.96	25.22
Debt / Equity Ratio	0.48	0.01	0.01	0.15	0.40	0.64
Debt / EBITDA Ratio	7.02	0.12	0.13	2.09	2.74	6.42
Debt / FCF Ratio	14.66	0.08	0.13	0.70	4.63	9.11
Asset Turnover	0.21	0.19	0.17	0.19	0.18	0.11
Inventory Turnover	6.74	1.71	1.88	4.38	3.50	4.20
Quick Ratio	23.66	8.05	12.49	2.50	10.39	4.70
Current Ratio	24.69	8.93	14.15	2.67	11.15	5.00
Return on Equity (ROE)	5.42%	-0.53%	8.29%	-0.74%	9.98%	0.89%
Return on Assets (ROA)	1.48%	1.66%	0.79%	0.18%	3.11%	1.80%
Return on Invested Capital (ROIC)	3.36%	-6.59%	1.64%	-0.07%	8.50%	7.45%
Return on Capital Employed (ROCE)	2.00%	2.50%	1.30%	0.50%	5.30%	3.30%
Earnings Yield	1.29%	-0.20%	4.19%	-2.96%	2.21%	-0.19%
FCF Yield	0.82%	4.70%	3.70%	11.12%	2.71%	3.13%
Buyback Yield / Dilution	-6.20%	-3.00%	-5.27%	2.19%	-2.50%	14.84%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q